|Bid||859.00 x 0|
|Ask||861.00 x 0|
|Day's range||848.39 - 895.00|
|52-week range||848.39 - 1,678.00|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||39.46|
|Earnings date||13 Apr 2022 - 18 Apr 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1,871.00|
Jabran Khan explores a FTSE 250 stock he believes is primed to grow in the long term and explains why he would add shares to his holdings at current levels. The post 1 FTSE 250 to buy for long-term growth appeared first on The Motley Fool UK.
OTTAWA, Ontario, January 24, 2022--Virica Biotech signs a new partnership with Oxford Biomedia to improve the manufacturing of lentiviral vector gene therapies using VSEs™.
With UK stocks on the rise in 2022, Zaven Boyrazian shares his top pick from his own portfolio that could deliver triple-digit returns. The post 1 UK stock I’d buy in 2022 to try to double my money appeared first on The Motley Fool UK.